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Colecistostomia percutânea no tratamento da colecistite aguda litiásica 
Percutaneous cholecystostomy in the management of calculous acute cholecystitis 
Abstract 
Background: Laparoscopic cholecystectomy is the gold-standard treatment in acute cholecystitis. However, 
percutaneous cholecystostomy stands as an alternative therapeutic approach among the elderly or patients 
with several comorbidities. 
Objective: The aim of this study is to clarify the role of percutaneous cholecystostomy in calculous acute 
cholecystitis treatment and to elucidate about its association with the surgical treatment.  
Methods: In December 2016, a systematic database search on PubMed, Scopus and Web of Science was 
conducted to identify articles on percutaneous cholecystostomy published from January 2013 to November 
2016, using the query “(acute cholecystitis OR severe cholecystitis) AND (cholecystostomy OR percutaneous 
cholecystostomy OR cholecystostomy tube)”. In total, 290 articles were found and then submitted to 
inclusion and exclusion criteria. 
Results: A total of 13 records involving 1130 patients from 10 different countries met all inclusion criteria 
and were therefore included in this systematic review. All studies found eligible concluded percutaneous 
cholecystostomy is a potentially safe and effective therapeutic approach among high-risk surgical patients in 
the setting of acute cholecystitis. Percentage of patients undergoing percutaneous cholecystostomy 
followed by cholecystectomy varied between 7.2% and a maximum of 66.7%, with a conversion rate 
fluctuating between 0.0% and 66.7%. Complication and mortality rates ranged from 2.2% to 41.7% and 0.0% 
and 43.2%, respectively. 
Conclusions: Percutaneous cholecystostomy is generally considered safe and effective among high-risk 
surgical patients diagnosed with acute cholecystitis. 





Acute cholecystitis, an inflammatory condition affecting the gallbladder, mainly associated to lithiasis, stands 
as one of the most relevant surgical causes of emergency hospital admissions 1,2. 
Laparoscopic cholecystectomy has been defined as the gold-standard therapeutic approach, with 
recommendations highlighting the importance of an early surgical intervention as soon as the diagnosis is 
established3.  
While very common, acute cholecystitis in the elderly and comorbid populations may have an atypical 
symptomatic presentation and further complicate, prompting difficult surgical treatment4. Agnieszka 
Popowicz et al. point out early cholecystectomy in high-risk patients might be associated with significant 
morbidity and mortality5. In fact, the intrinsic vulnerability of patients of an advanced age and several 
comorbidities may negatively impact on surgical outcomes, with perioperative morbidity and mortality rising 
up to 41% and 18%, respectively1.  
Pioneered by R.W. Radder in the 80s5, ultrasound-guided percutaneous cholecystostomy consists of a 
minimally invasive procedure under local anaesthesia, and is generally considered safe5,6.  
According to Wang et al., symptomatic relief up until 72 hours has been registered among more than 80% of 
patients submitted to cholecystostomy, as well as a procedure-associated mortality being inferior to 3%1. 
Therefore, percutaneous cholecystostomy may play an increasingly important role in treating severe acute 
cholecystitis diagnosed in high-risk surgical patients, with substantial co-morbidities6. Moreover, performing 
percutaneous cholecystostomy in patients not eligible for surgery at the time of diagnosis may not only 
serve as bridging therapeutic approach between medical treatment and surgery, but also as a potentially 
definitive treatment measure5. Indeed, Ye Rim Chang et al. indicate 88.3% of high-risk surgical patients who 
underwent percutaneous cholecystostomy showed no relapse during a follow-up period of almost two 
years7. 
Notably, the procedure has been applied to decreasingly co-morbid patients recently1,8. In fact, comparing 




submitted to drainage the decade before 1995, whereas only 80% were received such high ASA 
classifications when receiving the procedure the decade after8, with mortalities having dropped from 22.1% 
to 13.3% since that time8. Such improved mortality rate may put in evidence the importance of patient 
selection when deciding on cholecystostomy indication8. 
However, the role of cholecystostomy as an alternative treatment option to early cholecystectomy remains 
poorly established5. Campanile et al. enhance the need of further investigation on the field in order to clarify 
its importance and indication criteria, given the heterogeneity in defining high-risk surgical patients3. 
Besides, literature is not consensual regarding performance of an elective laparoscopic cholecystectomy 
subsequently to percutaneous cholecystostomy, nor as far as the precise time interval between drainage 
and surgery is concerned3.   
According to the widely used 2013 Tokyo Guidelines, severe acute cholecystitis cases treated with 
percutaneous cholecystostomy must be only submitted to cholecystectomy three months later6. Yet, 
different studies highlight the advantages of early surgery even in patients of worse surgical profiles. In a 
systematic review published in 2009, Windbladh et al. describe higher post-cholecystostomy mortality when 
compared to early cholecystectomy in non-surgical patients, again emphasizing the need of clinical trials on 
the subject9. Moreover, Campanile et al. claim in-hospital mortality associated with cholecystostomy is said 
to vary between 4 and 50%, signalling study limitations on this matter and how each investigation might 
define high-risk surgical individuals in divergent manners3. Also, need for surgery has been less investigated 
than conservative management, particularly in high surgical risk patients3. 
Given the absence of consistent evidence in literature on how and when to recommend percutaneous 
cholecystostomy in the treatment of acute cholecystitis, this systematic review aims to help validate this 
procedure as a therapeutic approach, to precise its potential indications and to clarify its association with 





In December 2016, a literature search was performed to identify studies focusing on the role of 
percutaneous cholecystostomy as a treatment option for acute cholecystitis. 
A systematic search on PubMed, Scopus and Web of Science was conducted spanning from January 2013 to 
November 2016. Studies were identified using the following query: “(acute cholecystitis OR severe 
cholecystitis) AND (cholecystostomy OR percutaneous cholecystostomy OR cholecystostomy tube)”. Only 
studies in humans were considered. 
A total of 290 articles were initially retrieved, 110 from PubMed, 25 from Scopus and 155 from Web of 
Science. Repeated articles among different databases were excluded, remaining 167 records for assessment. 
Reference lists of eligible articles were hand-searched. 
All articles written in languages other than Portuguese or English were excluded, as well as reviews, clinical 
cases, editor letters or video articles. Additionally, articles about acute acalculous cholecystitis or other 
conditions other than acute cholecystitis or associated with a malignant etiology were also excluded. Finally, 
studies involving less than thirty patients were considered small unrepresentative sample populations, 
having been set aside too. Therefore, from 167 records assessed, 36 full-text articles were assessed for 
eligibility. 
Inclusion criteria were as it follows: populations which were fully characterized according to gender, mean 
age and American Society of Anaesthesiologists (ASA) physical status classification system, further including 
information on percutaneous cholecystostomy indication, outcomes of percutaneous cholecystostomy, 
outcomes of an eventual procedure of cholecystectomy following percutaneous cholecystostomy, 
procedure-associated complications, global mortality and eventual re-admissions. 
Following these criteria, 23 from 36 studies were excluded, and the remaining 13 papers were included in 





Among 13 articles found eligible, all studies stressed the effectiveness and safety of percutaneous 
cholecystostomy as a symptomatic therapeutic approach among high-risk patients, as in bearing less 
favourable surgical profiles. 
A total of 1130 patients prevenient from 10 different countries were counted. Characterization of all 13 
study populations is depicted in Table 1, reported outcomes are covered by Table 2 and specific 
considerations made about each study were as it follows.  
Travis J. Smith et al. described an association between percutaneous cholecystostomy tubes placement and 
elderly age and increased number of comorbidities8, namely cardiovascular disease (66% vs 26%, p = 0.001), 
diabetes (27% vs 13%, p = 0.001), and mean Charlson comorbidity index (3.27 vs 1.07, P = 0.001). 
Retrospectively comparing trends of cholecystostomy performance during the 90s versus the 00s, authors 
also observed global decreasing mortality rates8, with mortality at 30-day follow-up lowering from 36% to 
12% among patients submitted to drainage (p = 0.001). 
According to Chung-Kai Chou et al., patients diagnosed with acute severe cholecystitis who were considered 
unfit for surgery and underwent early percutaneous cholecystostomy showed declining hospital length of 
stay (15.8 ± 12.9 vs 21.0 ± 17.5 days in patients with late procedure) and procedure-related bleeding (0.0% 
vs 5.0%, p = 0.018)10.  
Asgaut Viste et al. highlight only minor complications related to the procedure (reported among 12.5% 
patients) with predominant successful tube insertion and rapid symptom relief experienced in 97% of 
individuals who enrolled in the study11. E. Atar et al. put in evidence very satisfying rates of technically 
successful procedures, with effective tube insertion among all 81 critically ill patients and no reports of 
major complication events12.  
Furthermore, cholecystostomy showed to improve survival among high-risk individuals included in a study 




improvement. Indeed, authors describe that cholecystostomy was performed at a median of 2 days after 
establishing acute cholecystitis diagnosis, avoiding high failure rates mentioned in literature13. 
As far as how cholecystostomy might be related with subsequent surgery, a Norwegian retrospective 
analysis conducted by Asgaut Viste et al. concluded that only one-third of 104 patients submitted to 
percutaneous biliary drainage were later cholecystectomized11. Moreover, Enver Zerem et al. affirm high-
risk surgical patients might not even need further treatment once percutaneous cholecystostomy is 
performed14. E. Atar et al. also focus on the efficacy of conservatively treating critical patients with acute 
cholecystitis, stating that surgical outcomes after percutaneous cholecystostomy are superior to those of 
cholecystectomy only12. Dividing and comparing patients in two subsets according to their age (group 1 
corresponding to non-elderly patients, age ≤ 70 years, and group 2 including all elderly patients, age > 70 
years), Wei-Chen Lin et al. conclude high-risk elderly and substantially comorbid patients should be early 
identified as such and submitted to cholecystostomy, as they may benefit not only from better clinical 
outcomes, with a decrease in hospital length of time and associated morbidity, but also from better 
eventual surgical outcomes, enabling effective performance of delayed laparoscopic cholecystectomy15. 
Byung Hyo Cha et al. further define percutaneous cholecystostomy as the best definitive therapeutic option 
for those with acute cholecystitis who are not eligible for surgery at diagnosis, adding that certain cases may 
be appropriate for safe drainage tube removal16.  
When investigating which post-drainage clinical circumstances might predict eventual later surgery, Won 
Seok Janga et al. found advanced patient age, higher increased American Society of Anaesthesiologists (ASA) 
score and history of cerebrovascular accident (CVA) to be statically significant risk factors17. 
Despite all defending cholecystostomy as safe and effective in treating severe cases of acute cholecystitis, 
five of thirteen studies made remarks on possible conflicts concerning the procedure. 
Qingming Ni et al. enhanced the fact that emergent cholecystectomy should be performed in patients 
eligible for surgery as soon as acute cholecystitis is diagnosed, despite recognizing the role of percutaneous 




Even though only a minor part of all patients retrospectively reviewed by Pandanaboyana Sanjay et al. 
underwent later surgery, authors noted higher risk of conversion to open cholecystectomy among patients 
who had been submitted to percutaneous cholecystostomy19. Also, acute cholecystitis recurrence was 
registered in one in each four patients during study follow-up19. The study has also put in evidence the 
correlation between percutaneous cholecystostomy and high mortality rate due to sepsis at hospital 
admission, as well as 1-year mortality due to other causes unrelated to cholecystostomy19.  
Mehrdad Nikfarjam et al. additionally observed that a substantial proportion of patients required later 
surgery, with 9 out of 32 patients undergoing surgery at a median of 73 days since drainage20. This particular 
study also found hypotension and absence of common bile duct filling on initial cholangiography to be 
independent prognostic factors, associated with long-term survival reduction20. 
Further prognostic factors were detected by Khang Wen Pang et al.21. In fact, authors predicted an increased 
cholecystitis recurrence risk among patients presenting with higher alkaline phosphatase (ALP) at hospital 
admission and patients with acute cholecystitis complicated with acute myocardial infarction (AMI). 
Therefore, investigators state that these specific groups of patients might benefit from definitive 
cholecystectomy, while taking part in the consensual opinion that surgical profile should persevere as the 









Widely recognized Tokyo Guidelines, recently revised in 2013, have recommended emergent percutaneous 
cholecystostomy and subsequent interval cholecystectomy for cases of severe acute cholecystitis, classified 
as grade III and moderate cases, or grade II, only for when patients appear to be refractory to conservative 
treatment13.  
All studies included in this review have recognized a global beneficial use of cholecystostomy in selected 
patients, particularly among those considered non-eligible for cholecystectomy. Indeed, thorough search 
has put in evidence an historical belief that correlates populations of an advanced age, in critical clinical 
condition or with several comorbidities with an inappropriate surgical profile. L.R. Jenkinson et al. have 
previously associated cholecystectomy performed in an elderly subset of patients with morbidity rates of up 
to 46% 19,22. Further claims have reported surgical procedures in acute settings among high-risk individuals 
lead to up to 4.5% mortality rates along with 41% morbidity cases mainly due to anaesthetic intercurrences 
and intrinsic severe comordities15,23. 
In this demanding clinical context, cholecystostomy emerges as a potentially safe treatment choice for 
challenging patients, seemingly able to improve both prognosis as a single approach and outcome among 
cases requiring later cholecystectomy. In fact, symptomatic relief and sepsis treatment have been previously 
described among 86% of patients submitted to percutaneous drainage 9,20. Included in this review, the 
investigation led by Mehrdad et al. further attest symptomatic treatment and hospital discharge among 91% 
of patients who underwent cholecystostomy after having been considered unfit for general anaesthesia 20. 
As mentioned before, all remaining records included corroborate the advantageous indication for this 
purpose. Moreover, Byung Hyo Cha et al. obtained successful results when focusing on the role of 
percutaneous cholecystostomy as definitive management of individuals in critical condition, with no 
recurrences to register and tubes effectively removed in 75.6% of patients16. 
Despite the optimistic outlook, lengthy database searching for this review has revealed several papers 
which, despite not qualifying for inclusion criteria and therefore having been excluded, demonstrated 




recommended for better outcomes. A decade long retrospective analysis comprising more than 300 000 
patients, conducted in the University of California, San Diego24, found that patients submitted to 
cholecystostomy displayed lower risk of procedure-associated complications than patients who underwent 
surgery; however, mortality was reported to be significantly increased among cholecystostomy patients 
(odds ratio of 5.2, p < 0.001), as well as total hospital length of stay and charges associated.  Abi-Haidar et al. 
have also described not only association of percutaneous cholecystostomy with statistically significant 
longer hospital length of stay (p < 0.001), but also increased complication (p = 0.01) and hospital 
readmission rates (p = 0.006) when compared to early cholecystectomy, with 21.4% patients having been 
eventually readmitted25. Researchers add that even laparoscopic cholecystectomy conversion to open 
procedure, traditionally correlated with quite poor outcome scenarios, showcased better clinical 
performance, with decreased number of systemic (25.0% vs 43.1%), hepatobiliary (52.8% vs 68.6%) and 
other (2.8% vs 7.8%) complications comparing to percutaneous cholecystostomy25. 
Originally, a table comprising results systematically collected from all thirteen articles was created. However, 
multiple discrepancies were extensively detected as far as study designs were concerned. In fact, articles 
differed greatly in patient selection for procedure indication criteria, data collected, clinical outcomes 
sought and follow-up time. This has occasioned hazardous comparison between results found, thereby 
impairing further statistical analysis and weakening potential conclusions for cholecystostomy validation in 
acute cholecystitis treatment.  
As it has been previously stated in literature20, It is our opinion that only randomized controlled trials may 
effectively clarify  whether percutaneous cholecystostomy should be relied on to achieve safe and successful 
acute cholecystitis treatment. If so, clinical criteria should be formally established so as patients benefit from 
this procedure. Dutch CHOCOLATE (percutaneous cholecystostomy versus laparoscopic cholecystectomy) 
multicentre randomized controlled trial on acute cholecystitis treatment among surgical high-risk 






All studies included in this review affirm percutaneous cholecystostomy is as a safe procedure with largely 
successful outcomes when performed in high-risk surgical patients with acute cholecystitis, especially those 
of an advanced age or who bear significant comorbidities. However, further investigation is needed to 
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Figure 1. Flow diagram representing methods for data analysis throughout all phases of this systematic review. 
Abovementioned are discriminated all articles found, included and excluded, and exclusion criteria applied. PC, 
percutaneous cholecystostomy; PC+CCY, percutaneous cholecystostomy followed by cholecystectomy. 
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(n = 131) 
 languages other than Portuguese or English 
 reviews, clinical cases, editor letters, video 
articles 
 records on acute acalculous cholecystitis 
 records on other medical conditions  
 records on malignant conditions  
 records with study populations of less than 30  
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Study Year Country Design Number of 
patients 
F:M Mean age, years Number of 
patients with 
ASA≥3 
Qingming Ni et al. 2015 China R 62 34:28 72.1 
 
44 (71.0%) 
Charleen Shan Wen Yeo 
et al. 
 
2015 Singapore R 103 46:57 80 (43-105) 88 (85.4%) 
Chung-Kai Chou et al. 2015 Taiwan R 209 60:149 74.54 200 (95.7%) 
Asgaut Viste et al. 2015 Norway R 104 47:57 73.5 (22-96) 44 (42.3%) 
Won Seok Janga et al. 2014 South Korea R 93 52:41 73.8 ± 12.1 48 (51.6%) 
Enver Zerem et al.  2014 Bosnia and 
Herzegovina 
R 36 24:12 75 ± 9.7 
 
25 (72.2%) 
E. Atar et al.  
 
2014 Israel R 81 33:48 82 (47-99) 81 (100%) 
Byung Hyo Cha et al.  2014 South Korea R 82 39: 43 72.1 ± 13.7 82 (100%) 
Mehrdad Nikfarjam et 
al.  
 
2013 Australia P 32 16:16 78 (45-97) 32 (100%) 
Khang Wen Pang et al. 2016 Singapore R 71 28:43 73 (38-96) 71 (100%) 
Wei-Chen Lin et al.  2016 Taiwan R 61 30:31 80.3 ± 9.3 58 (95.1%) 
Pandanaboyana Sanjay 
et al.  
 
2013 New Zealand R 53 21:32 74 (14-93) 
 
49 (92.5%) 
Travis J. Smith et al. 2013 EUA R 143 50:93 72.0 ± 13.5 117 (81.8%) 
 
Table 1. Characterization of all 13 study populations according to year of publication, country of origin, design of study 
(R - retrospective; P - prospective), number of patients included, female to male ratio (F:M), mean age of patients (in 






Study PC only PC+CCY Conversion 
rate 
Complications Mortality Readmissions 
Qingming Ni et al. 
 
36 26 (41.9%) 19.2% 3 (4.8%) 0 (0.0%) 4 (6.4%) 
Charleen Shan Wen Yeo 
et al. 
 
61 42 (40.7%) 15.0% 10 (9.7%) 13 (12.6%) 7 (6.8%) 
Chung-Kai Chou et al.  101 95 (45.5%) - 26 (12.4%) 13 (6.2%) 20 (9.6%) 
Asgaut Viste et al.  
 
70 30 (28.8%) 7.7% 13 (12.5%) 4 (3.8%) 0 (0.0%) 
Won Seok Janga et al.  31 62 (66.7%) 3.2% 2 (2.2%) 2 (2.2%) 6 (6.5%) 
Enver Zerem et al.  
 
23 6 (16.7%) 16.7% 15 (41.7%) 7 (19.4%) 5 (13.9%) 
E. Atar et al. 
 
10 36 (44.4%) 11.1% 6 (7.4%) 35 (43.2%) 2 (2.5%) 
Byung Hyo Cha et al.  47 35 (42.7%) 0.0% 2 (2.4%) 2 (2.4%) 0 (0.0%) 
Mehrdad Nikfarjam et al.  21 9 (28.1%) 0.0% 6 (18.8%) 3 (9.4%) 14 (43.8%) 
Khang Wen Pang et al.  33 32 (45.1%) 11.5% 20 (28.2%) 23 (32.4%) 7 (9.9%) 
 
Wei-Chen 































23 18 (34.0%) 66.7% 7 (13.2%) 12 (22.6%) 13 (24.5%) 
Travis J. Smith et al. 67 59 (41.3%) 14.0% 21 (14.7%) 17 (11.9%) 0 (0.0%) 
 
Table 2. Outcomes of all 13 studies included, i.e. number of patients who underwent percutaneous cholecystostomy 
only (PC only), number of patients who underwent percutaneous cholecystostomy followed by cholecystectomy 
(PC+CCY), conversion rate to open cholecystectomy, number of all complications recorded, global mortality observed 
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A Revista Portuguesa de Cirurgia (RPC) publica trabalhos originais de teor biomédico 
relacionados com a área de conhecimento da Cirurgia, tendo como objetivo a divulgação do 
conhecimento científico e a promoção da boa prática médica.  
A Revista subscreve os princípios definidos pelo COPE (Committee on Publication Ethics, em 
www.publicationethics.org) e os requisitos para apresentação de artigos em revistas biomédicas 
elaboradas pelo International Commitee of Medical Journal Editors (em www.ICMJE.org). 
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de Política Editorial (Editorial Policy Statements) emitidas pelo Council of Science Editors, sobre 
a responsabilidade e direitos dos editores das revistas com arbitragem científica. 
(http://www.councilscienceeditors.org) 
Todos os manuscritos submetidos para publicação são sujeitos a revisão por pares, feita de 
forma cega, por revisores externos ao corpo editorial, exceptuando-se os casos identificados 
nestas normas. 
Na avaliação dos manuscritos submetidos, o editor seguirá as recomendações publicadas pelo 
Equator Network (em www.equator-network.org), recomendando aos autores a consulta da 
checklist que se adequa ao tipo trabalho a publicar.   
Tem periodicidade trimestral, sendo publicada exclusivamente online a partir do número 30.  
É publicada de acordo com os princípios de acesso livre. 
(http://www.budapestopenaccessinitiative.org/boai-10-recommendations) 
Editor e Propriedade: 
A RPC é publicada e propriedade da Sociedade Portuguesa de Cirurgia 
Sociedades Cientificas 
Órgão Oficial da Sociedade Portuguesa de Cirurgia. 
Idiomas de publicação 
A RPC publica artigos redigidos em Português, Inglês, Espanhol e Francês. 





Critérios de Autoria 
A RPC subscreve o “ICMJE Recommendations for the Conduct, Reporting, Editing, and 
Publication of Scholarly work in Medical Journals” ( www.ICMJE.org). 
A atribuição de autoria implica a satisfação de 4 condições: 
1. Ter contribuição intelectual substancial direta, no desenho e elaboração do artigo. 
2. Participar na análise e interpretação dos dados. 
3. Participar ativamente na escrita do manuscrito, na revisão dos rascunhos, na revisão crítica 
do conteúdo, ou na aprovação da sua versão final. 
4. Autores concordarem que são responsáveis pela exatidão e integridade de todo o trabalho. 
Todos os que contribuíram para o artigo, mas cuja participação não obedeça às condições atrás 
definidas, devem ser referenciados na secção "Agradecimentos". 
Ser apresentado como autor não cumprindo estes critérios, é considerado má prática. 
Para maior transparência, deverá ser submetido a "Declaração de Autoria e Conflito de 
Interesses", onde deve ser especificado o contributo de cada autor para o manuscrito 
apresentado e assinada por todos os autores. 
Conflitos de Interesse 
Todo o conteúdo publicado, incluindo as opiniões expressas, é da exclusiva responsabilidade dos 
autores, que devem revelar no momento da submissão a existência ou não de conflitos de 
interesse, na "Declaração de Autoria e Conflitos de Interesse". Essa informação será mantida 
confidencial durante a revisão do manuscrito e não influenciará a decisão editorial, mas será 
publicada caso o artigo venha a ser aceite para publicação. 
No caso de existência de dúvidas relativamente ao que constitui um Conflito de Interesse devem 
os autores contactar o Editor Chefe (editorchefe@spcir.com). 
 
Direitos Autorais (Copyright) 
No momento da submissão do manuscrito, deve ser submetido documento assinado por todos 
os autores com transferência dos direitos de autor para a Revista Portuguesa de Cirurgia / 
Sociedade Portuguesa de Cirurgia, estando implícita a vinculação da Revista Portuguesa de 
Cirurgia / Sociedade Portuguesa de Cirurgia, a partir do momento de aceitação do artigo para 
publicação. 
Se o artigo contiver extratos (incluindo ilustrações) de, ou for baseado no todo ou em parte em 
outros trabalhos com copyright, é da responsabilidade dos autores a obtenção da autorização 
escrita dos proprietários para sua reprodução em todos os territórios, edições e em todos os 
meios de expressão e línguas. Todos os formulários de autorização devem ser fornecidos aos 
editores quando da submissão do artigo. 
Relativamente à utilização por terceiros de artigos publicados a Revista Portuguesa de Cirurgia 
rege-se pelos termos da licença Creative Commons “Atribuição – uso Não-Comercial – Proibição 
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de Realização de Obras derivadas (by-nc-nd)”. Informação disponível em: 
(http://creativecommons.org/licenses/by-nc-nd/3.0/deed.pt) 
A Revista Portuguesa de Cirurgia reserva-se o direito de comercialização do artigo. 
Consentimento informado e aprovação ética 
A publicação de fotografias, vídeos ou descrições escritas de doentes implica que os autores 
submetam documento de consentimento informado assinado pelo doente ou seu 
representante legal.  
Os autores devem comunicar expressamente que o trabalho de investigação que esteve na base 
do artigo original  foi aprovado pela Comissão de Ética da Instituição de acordo com a declaração 
de Helsínquia (consultar em www.wma.net) e explicita-lo na secção de material e métodos do 
manuscrito. 
Política de Autoarquivamento 
Imediatamente após a publicação online, os autores ficam autorizados a disponibilizar os seus 
artigos em repositórios institucionais, desde que mencionem a publicação onde foi publicado 
de acordo com as normas em vigor e utilizem ficheiro PDF original do editor. 
Processo Editorial 
Estilo 
Os artigos devem ser escritos de acordo com o “Uniform Requirements for Manuscripts 
Submitted to Biomedical Journals” (http://www.icmje.org/about-icmje/faqs/icmje-
recommendations/ ) 
O Editor reserva-se o direito de fazer alterações ao texto desde que as mesmas não desvirtuem 
o conteúdo, mas que adaptem o estilo de escrita ao padrão da publicação. 
Submissão 
Os artigos são submetidos online, por autores registados na página da Revista Portuguesa de 
Cirurgia em http://revista.spcir.com/index.php/spcir/about/submissions#onlineSubmissions 
Todos os campos solicitados no sistema de submissão online devem ser preenchidos. Para 
desambiguação do nome do autor, sugere-se a utilização do identificador ORCID para cada 
autor, que poderá ser obtido em http://orcid.org . 
No momento da submissão é definido como "Autor Correspondente", aquele que em nome de 
todos os co-autores, centraliza os contactos durante o processo de submissão e revisão, sendo 
o responsável perante o Editor por garantir que sejam cumpridos todos os requisitos para 
publicação do manuscrito. O seu contacto será publicado no manuscrito. 
O manuscrito deve ser submetido sob a forma de documento em formato editável (.doc, .docx, 
.rtf). Não são aceites artigos submetidos no formato PDF, ou outro não editável. 
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Material muito extenso para a publicação com o artigo, designadamente tabelas extensas ou 
instrumentos de recolha de dados, poderão ser publicados sendo referenciado como Material 
suplementar. 
O artigo deve seguir a seguinte estrutura: 
Na primeira página:  
- Título no idioma de publicação e em inglês. 
- Nome de todos os Autores (primeiro e último nome) com os títulos académicos e/ou 
profissionais e respectivas afiliação (departamento, instituição, cidade, país). 
- Subsídio (s) ou bolsa(s) que contribuíram para a realização do trabalho.  
- Morada e e-mail do Autor Correspondente. 
Na segunda página: 
- Título 
- Resumo no idioma de publicação e em inglês. 
- Palavras-chave (Keywords). Um máximo de 5 utilizando a terminologia que consta no 
Medical Subject Headings (MeSH), http://www.nlm.nih.gov/mesh/MBrowser.html . 
Nas páginas subsequentes: 
- Restante texto do artigo, considerando o Tipo de trabalho e a Secção da revista onde 
será publicado. Para que o processo de revisão do artigo seja o mais célere possível, o 
artigo deverá ter o texto cuidado e obedecendo aos limites impostos para o respectivo 
tipo de artigo.  
 
Após submissão autor correspondente será informado por email da sua recepção, podendo 
consultar a evolução do processo de revisão na sua area no site da revista. 
Secções e Tipos de Trabalhos 
 
Agenda 
Nesta secção serão publicitados eventos futuros de cariz técnico-científico, cujo corpo editorial 
considerou de relevo 
Artigos de Opinião 
Solicitados ou não pelo Editor Chefe, serão preferencialmente artigos de reflexão sobre 
educação médica, ética e deontologia médica. Devem estar estruturados com Resumo e 
Palavras-chave em Português e Inglês. Não poderão exceder as 2500 palavras, 2 imagens e as 5 
referências bibliográficas. Não serão submetidos a revisão por pares sendo a sua aceitação para 
publicação da exclusiva competência do Editor Chefe.  
Artigos de Revisão 
Os Artigos de Revisão constituirão monografias sobre temas atuais, avanços recentes, conceitos 
em evolução rápida e novas tecnologias. 
Os Editores encorajam a apresentação de artigos de revisão ou meta-análises sobre tópicos de 




Os Editores poderão solicitar diretamente Artigos de Revisão, não sendo estes submetidos a 
revisão por pares sendo a aceitação do mesmo para publicação da exclusiva competência do 
Editor Chefe. 
Artigos Originais 
São artigos inéditos referentes a trabalhos de investigação, casuística ou que, a propósito de 
casos clínicos, tenham pesquisa sobre causas, mecanismos, diagnóstico, evolução, prognóstico, 
tratamento ou prevenção de doenças. O texto não poderá exceder as 5000 palavras e as 50 
referências bibliográficas. Serão submetidos a revisão por pares. 
Cadernos Especiais 
Nesta secção serão publicados preferencialmente artigos a convite do Editor Chefe, focando 
temática designada previamente e de acordo com a orientação editorial do mesmo. Estes artigos 
não deverão exceder as 5000 palavras as 5 imagens e as 25 referências bibliográficas. Não serão 
submetidos a revisão por pares sendo a aceitação do mesmo para publicação da exclusiva 
competência do Editor Chefe. 
Casos Clínicos 
São relatos de Casos, de preferência raros, didáticos ou que constituam formas pouco usuais de 
apresentação.  
A convite dos editores poderão ser publicados comentários ao caso. 
Não deverão exceder as 1800 palavras, 4 imagens e 15 referências bibliográficas. 
Serão submetidos a revisão por pares. 
Controvérsias 
São trabalhos elaborados a convite dos Editores. Relacionar-se-ão com temas em que não haja 
consensos e em que haja posições opostas ou marcadamente diferentes. Serão sempre pedidos 
2 pontos de vista, defendendo opiniões opostas. O texto de cada um dos autores não deverá 
exceder as 2500 palavras, 2 imagens e 10 referências bibliográficas.  
Editoriais 
Os editoriais são apenas submetidos a convite do Editor Chefe, relacionando-se com temas da 
atualidade, ou com temas importantes publicados nesse número da Revista. Não serão 
submetidos a revisão por pares. Não têm resumo nem palavras-chave e não deverão exceder 
1800 palavras tendo no máximo 5 referências bibliográficas.  
Erratas e Retracções 
Nesta secção serão publicadas todas as alterações ou retrações a um artigo publicado 
previamente e cujos erros tenham sido detectados posteriormente à sua publicação. 
História e Carreiras 
Nesta secção serão publicados artigos inéditos referentes a factos e figuras históricas de relevo 
para a Cirurgia em Portugal e no Mundo. O texto não poderá exceder as 5000 palavras e as 
25referências bibliográficas. Serão submetidos a revisão por pares. 
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Imagens para Cirurgiões 
Esta secção destina-se à publicação de imagens (clínicas, radiológicas, histológicas, cirúrgicas) 
relacionadas com casos cirúrgicos. O número máximo de figuras e quadros será de 3. As imagens 
deverão ser de muito boa qualidade técnica e de valor didático. O texto que poderá acompanhar 
as imagens deverá ser limitado a 250 palavras. Serão submetidos a revisão por pares. 
Leituras Recomendadas 
Secção onde serão publicados revisões sumárias de livros, material multimédia ou outros, que 
tenham particular relevância para atualização científica e técnica. Limitados a 250 palavras e 1 
ilustração. Não submetido a revisão por pares. 
Linhas de Orientação Recomendadas (Guidelines) 
Nesta secção serão publicadas recomendações para a prática clinica, preferencialmente de 
grupos ou entidades de referência nas áreas clinicas em causa. A sua publicação depende da 
aprovação pelo Editor Chefe com o parecer do Editor Cientifico. 
Passos Técnicos 
Artigos com foco em técnica cirúrgica ou relativos a procedimentos cirúrgicos em que os autores 
apresentam e descrevem aspetos particulares da mesma com interesse pela sua inovação, 
resultados e reprodutibilidade. Limitado a 5000 palavras e 25 referências bibliográficas. Sem 
limite de ilustrações, sendo o critério de escolha final determinado pelo Editor Chefe. 
Textos Fundamentais 
Textos que, pela sua relevância científica, são considerados pelo Editor Chefe como relevantes 
para o conhecimento na área da cirurgia.  
Resumos 
Nesta secção serão publicados resumos de apresentações em reuniões da Sociedade Portuguesa 
de Cirurgia ou entidades afiliadas. Resumos dos trabalhos têm avaliação por pares. 
